MedTrace Logo

Efficacy Study of a Bioelectric Dressing to Treat Wounds Caused by Curettage and Electrodesiccation

NCT01004055 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2009-10-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether a bioelectric wound dressing, a silver-coated dressing, or a silver-foam dressing are effective in the treatment of wounds resulting from curettage and electrodesiccation of skin lesions.

Conditions

  • Wound Healing
  • Wound Infection

Interventions

DEVICE

Procellera™ Antimicrobial Wound Dressing

Dressing indicated for partial and full-thickness wounds. Dressing changes every 2-3 days, more frequently if needed

DRUG

ACTICOAT™ Antimicrobial Barrier Dressing

Dressing changes every 2-3 days, more frequently if needed

DRUG

Mepilex® Ag Silver Foam Dressing

Dressing changes every 2-3 days, more frequently if needed

Sponsors & Collaborators

  • Vomaris Innovations

    lead INDUSTRY

Principal Investigators

  • Scott N Sheftel, MD · Sheftel Associates Dermatology, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-08-31
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01004055 on ClinicalTrials.gov